User profiles for Daniela Maria Cirillo
Daniela Maria CirilloIRCCS San Raffaele Scientific Institute Verified email at hsr.it Cited by 40642 |
Macrophage‐dependent induction of the Salmonella pathogenicity island 2 type III secretion system and its role in intracellular survival
DM Cirillo, RH Valdivia, DM Monack… - Molecular …, 1998 - Wiley Online Library
Salmonella pathogenicity island 2 (SPI‐2) encodes a putative type III secretion system necessary
for systemic infection in animals. We have investigated the transcriptional organization …
for systemic infection in animals. We have investigated the transcriptional organization …
Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages
Generalist and specialist species differ in the breadth of their ecological niches. Little is known
about the niche width of obligate human pathogens. Here we analyzed a global collection …
about the niche width of obligate human pathogens. Here we analyzed a global collection …
Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement
…, B Williams, WW Yew, JP Zellweger, DM Cirillo - 2014 - Eur Respiratory Soc
The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis
(TB) substantially challenges TB control, especially in the European Region of the World …
(TB) substantially challenges TB control, especially in the European Region of the World …
[HTML][HTML] Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project
…, S Andres, AM Cabibbe, DM Cirillo… - The Lancet infectious …, 2016 - thelancet.com
Background Pyrazinamide and fluoroquinolones are essential antituberculosis drugs in new
rifampicin-sparing regimens. However, little information about the extent of resistance to …
rifampicin-sparing regimens. However, little information about the extent of resistance to …
[HTML][HTML] Antimicrobial susceptibility testing of Mycobacterium tuberculosis complex isolates–the EUCAST broth microdilution reference method for MIC determination
…, G Kahlmeter, C Giske, M Santin, DM Cirillo… - Clinical Microbiology …, 2020 - Elsevier
Scope Several methods are used worldwide for antibiotic susceptibility testing (AST) for the
Mycobacterium tuberculosis complex (MTBC). The variability in the results obtained with …
Mycobacterium tuberculosis complex (MTBC). The variability in the results obtained with …
[HTML][HTML] The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis
Background Molecular diagnostics are considered the most promising route to achievement
of rapid, universal drug susceptibility testing for Mycobacterium tuberculosis complex (MTBC…
of rapid, universal drug susceptibility testing for Mycobacterium tuberculosis complex (MTBC…
[HTML][HTML] MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network
The continuous flow of new research articles on MDR-TB diagnosis, treatment, prevention
and rehabilitation requires frequent update of existing guidelines. This review is aimed at …
and rehabilitation requires frequent update of existing guidelines. This review is aimed at …
[HTML][HTML] MTBseq: a comprehensive pipeline for whole genome sequence analysis of Mycobacterium tuberculosis complex isolates
…, V Schleusener, MR De Filippo, P Beckert, DM Cirillo… - PeerJ, 2018 - peerj.com
Analyzing whole-genome sequencing data of Mycobacterium tuberculosis complex (MTBC)
isolates in a standardized workflow enables both comprehensive antibiotic resistance …
isolates in a standardized workflow enables both comprehensive antibiotic resistance …
[HTML][HTML] Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study
…, A Borbe-Reyes, DP Chin, DM Cirillo… - The Lancet Infectious …, 2018 - thelancet.com
Background In many countries, regular monitoring of the emergence of resistance to anti-tuberculosis
drugs is hampered by the limitations of phenotypic testing for drug susceptibility. …
drugs is hampered by the limitations of phenotypic testing for drug susceptibility. …
Defining the needs for next generation assays for tuberculosis
CM Denkinger, SV Kik, DM Cirillo… - The Journal of …, 2015 - academic.oup.com
To accelerate the fight against tuberculosis, major diagnostic challenges need to be addressed
urgently. Post-2015 targets are unlikely to be met without the use of novel diagnostics …
urgently. Post-2015 targets are unlikely to be met without the use of novel diagnostics …